4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000104
Chief Financial Officer sold 3,651 shares at $36.77 ($134,247)
- Chief Financial Officer acquired 7,472 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,472 | 37,521 | D | ||
| 2025-09-26 | Sale : show line 2 in the form 10b5-1 | −3,651 | $36.77 | $134,247 | 33,870 | D |
| Open-market sales · 3,651 sh · avg $36.77 · $134,247 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-26 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −7,472 | 0 | D |
Loading xslF345X05/wk-form4_1759269358.xml…